Bayer-Vitiva partnership
This article was originally published in The Tan Sheet
Executive Summary
Bayer Pharmaceuticals and Vitiva have signed an agreement to develop exclusive isolation of esters from marigold flowers, the firms announce July 5. The initiatve is related to Bayer's registered patent for a natural OTC product based on marigold flower extract, a press release adds. The partnership will "stimulate development of innovative products and will deliver new solutions for consumers who prefer to use natural ingredients," Vitiva says. Bayer Pharmaceuticals is part of the new Global Pharmaceutical Division that was established Jan. 1 and grew out of the former Biological Products and Pharmaceutical Division...